542 related articles for article (PubMed ID: 27439107)
1. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
[TBL] [Abstract][Full Text] [Related]
2. High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).
Seliger SL; Hong SN; Christenson RH; Kronmal R; Daniels LB; Lima JAC; de Lemos JA; Bertoni A; deFilippi CR
Circulation; 2017 Apr; 135(16):1494-1505. PubMed ID: 28159799
[TBL] [Abstract][Full Text] [Related]
3. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
[TBL] [Abstract][Full Text] [Related]
4. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
Saunders JT; Nambi V; de Lemos JA; Chambless LE; Virani SS; Boerwinkle E; Hoogeveen RC; Liu X; Astor BC; Mosley TH; Folsom AR; Heiss G; Coresh J; Ballantyne CM
Circulation; 2011 Apr; 123(13):1367-76. PubMed ID: 21422391
[TBL] [Abstract][Full Text] [Related]
5. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
6. Obesity, subclinical myocardial injury, and incident heart failure.
Ndumele CE; Coresh J; Lazo M; Hoogeveen RC; Blumenthal RS; Folsom AR; Selvin E; Ballantyne CM; Nambi V
JACC Heart Fail; 2014 Dec; 2(6):600-7. PubMed ID: 25443112
[TBL] [Abstract][Full Text] [Related]
7. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
Masson S; Anand I; Favero C; Barlera S; Vago T; Bertocchi F; Maggioni AP; Tavazzi L; Tognoni G; Cohn JN; Latini R;
Circulation; 2012 Jan; 125(2):280-8. PubMed ID: 22139751
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.
Koenig W; Breitling LP; Hahmann H; Wüsten B; Brenner H; Rothenbacher D
Clin Chem; 2012 Aug; 58(8):1215-24. PubMed ID: 22634379
[TBL] [Abstract][Full Text] [Related]
9. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
[TBL] [Abstract][Full Text] [Related]
10. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.
deFilippi CR; de Lemos JA; Christenson RH; Gottdiener JS; Kop WJ; Zhan M; Seliger SL
JAMA; 2010 Dec; 304(22):2494-502. PubMed ID: 21078811
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.
Beatty AL; Ku IA; Christenson RH; DeFilippi CR; Schiller NB; Whooley MA
JAMA Intern Med; 2013 May; 173(9):763-9. PubMed ID: 23568589
[TBL] [Abstract][Full Text] [Related]
12. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
[TBL] [Abstract][Full Text] [Related]
13. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.
McEvoy JW; Lazo M; Chen Y; Shen L; Nambi V; Hoogeveen RC; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
Int J Cardiol; 2015; 187():651-7. PubMed ID: 25880403
[TBL] [Abstract][Full Text] [Related]
14. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.
Pokharel Y; Sun W; Virani SS; Nambi V; Hoogeveen RC; Chang PP; Ndumele CE; Solomon SD; Bozkurt B; Selvin E; Ballantyne CM; Deswal A
JACC Heart Fail; 2017 Jan; 5(1):56-63. PubMed ID: 28017350
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
[TBL] [Abstract][Full Text] [Related]
17. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
[TBL] [Abstract][Full Text] [Related]
18. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
Whelton SP; McEvoy JW; Lazo M; Coresh J; Ballantyne CM; Selvin E
Diabetes Care; 2017 Feb; 40(2):261-269. PubMed ID: 28108537
[TBL] [Abstract][Full Text] [Related]
19. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.
Felker GM; Mentz RJ; Teerlink JR; Voors AA; Pang PS; Ponikowski P; Greenberg BH; Filippatos G; Davison BA; Cotter G; Prescott MF; Hua TA; Lopez-Pintado S; Severin T; Metra M
Eur J Heart Fail; 2015 Dec; 17(12):1262-70. PubMed ID: 26333655
[TBL] [Abstract][Full Text] [Related]
20. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
